Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection)

NCT00470977 is registered in ClinicalTrials.gov with Manhattan Eye, Ear & Throat Hospital as lead sponsor.

NCT NCT00470977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00470977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy With Intravitreal Injection of Lucentis (Ranibizumab Injection)
Lead sponsor
Manhattan Eye, Ear & Throat Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2007
Completion date
December 31, 2010
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

best vitelliform macular dystrophy, multifocal (disorder), coats' disease, idiopathic retinal telangiectasia, multi-focal choroiditis, pathological myopia, polypoidal choroidal vasculopathy, pseudoxanthoma elasticum, retinal angiomatous proliferation, rubeosis iridis, von hippel lindau disease